Stacey is responsible for scouting, diligence, and negotiations on technologies. She manages alliances with academic partners and directs many aspects of new company creation.
Prior to ElevateBio, Stacey led diligence, commercial assessments, and strategy projects for L.E.K. Consulting’s Life Sciences practice. While there, she focused on a range of therapeutic areas and modalities, including immuno-oncology and gene therapy.
Stacey received her Ph.D. from Yale University, where she investigated pathogen-mimicking nanoparticles for vaccine delivery. She holds a B.S.E. in Cellular and Tissue Engineering from Duke University.